{"id":"doi:10.1038/nrd.2016.238","kind":"review","title":"Cornerstones of CRISPR–Cas in drug discovery and therapy","authors":["Christof Fellmann","Benjamin G. Gowen","Pei‐Chun Lin","Jennifer A. Doudna","Jacob E. Corn"],"author_count":5,"year":2016,"published":"2016-12-23","venue":"Nature Reviews Drug Discovery","cited_by":445,"doi":"10.1038/nrd.2016.238","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nrd.2016.238","archive_url":"https://space-kitty.com/papers/doi:10.1038/nrd.2016.238","updated":null,"pmid":"28008168","pmcid":null,"openalex_id":"W2565920990","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}